Dosimetry Analysis of 177Lu-PSMA-I&T in Patients with Low-Volume Oligometastatic Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the LUNAR Trial

By afschroeder • April 3, 2026

Ells Z, Meyer C, Kimura K, Wilhalme H, Cao M, Ludwig VB, Unterrainer LM, Sennung D, Nabong R, Felix C, Valle LF, Daley A, Czernin J, Dahlbom M, Kishan AU, Calais J. Dosimetry Analysis of ¹⁷⁷Lu-PSMA-I&T in Patients with Low-Volume Oligometastatic Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the LUNAR Trial. J Nucl Med. 2026 Apr 2:jnumed.125.271467. doi: 10.2967/jnumed.125.271467. Epub ahead of print. PMID: 41927282.

Tags: 177Lu, 177Lu-PSMA-I&T, Cardiology/Epi, DOM STAT, dosimetry, General Internal Medicine, oligorecurrent, prostate cancer, PSMA, Publications, SBRT, theranostics

Outpatient clinic visits before and after hospitalizations for heart failure with and without transthyretin amyloid cardiomyopathy

Haywood HB, Ikeaba U, Fonarow GC, Xu H, Selvaraj S, Lewsey SC, Alhanti B, McDermott JJ, Wright J, Vaduganathan M, Greene SJ. Outpatient clinic visits[...]

Reassessing alcohol consumption and cardiovascular disease by addressing bias in observational data: results from the Multi-Ethnic Study of Atherosclerosis

Srivatsa S, Farkouh EK, Stockwell T, Pike JR, Clay JM, Bey G, Nasir K, Budoff M, Naimi T, Farkouh ME. Reassessing alcohol consumption and cardiovascular[...]

Statistical Misinterpretation of Nonsignificant Results in Diabetes Randomised Clinical Trials

Sharifan A, Fonarow GC. Statistical Misinterpretation of Nonsignificant Results in Diabetes Randomised Clinical Trials. Diabetes Metab Res Rev. 2026 May;42(4):e70179. doi: 10.1002/dmrr.70179. PMID: 42106583.